Botanical species · safety record

Paullinia cupana

The EFSA Compendium of Botanicals holds 24 constituent measurements, 8 adverse-effect records and 2 genotoxicity assays for Paullinia cupana. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Paullinia cupana Kunth

24Constituent measurements
10Safety records
5Cited sources
522Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 522 licensed products naming Paullinia cupana as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry
  • Extract Type TBA

Source material stated

  • Caffeine
  • Cichorium intybus - Root
  • Freeze-dried seed
  • Fruit
  • Grain
  • Grain(s)
  • Graine
  • Guarana - seed

What the records describe

Constituents measured

  • Caffeine2
  • Retrorsine2
  • Theobromine2
  • Alkaloids1
  • Alpha-solanine1
  • Coniine1
  • Echimidine1
  • Gramine1
  • Harmaline1
  • Lycopsamine1

Plant parts

  • Live plants21
  • Seed9
  • Unspecified2

Preparations

  • Solvent extraction30

Effect types

  • Other toxicities6
  • None2

Target tissues

  • Urogenital: kidneys2
  • Lung1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
CaffeineSeedSolvent extraction4.28 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
TheobromineSeedSolvent extraction0.015 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
TheophyllineSeedSolvent extraction0.007 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
AlkaloidsLive plantsSolvent extraction< 0.7 PercentChromatographic testsNo resolvable identifier
Alpha-solanineLive plantsSolvent extraction< 2 PercentChromatographic testsNo resolvable identifier
CaffeineLive plantsSolvent extraction< 2 PercentChromatographic testsNo resolvable identifier
ConiineLive plantsSolvent extraction< 0.3 PercentChromatographic testsNo resolvable identifier
EchimidineLive plantsSolvent extraction< 0.1 PercentChromatographic testsNo resolvable identifier
GramineLive plantsSolvent extraction< 0.1 PercentChromatographic testsNo resolvable identifier
HarmalineLive plantsSolvent extraction< 6 PercentChromatographic testsNo resolvable identifier
LycopsamineLive plantsSolvent extraction< 0.2 PercentChromatographic testsNo resolvable identifier
MonocrotalineLive plantsSolvent extraction< 0.1 PercentChromatographic testsNo resolvable identifier
NicotineLive plantsSolvent extraction< 24 PercentChromatographic testsNo resolvable identifier
QuinidineLive plantsSolvent extraction< 5 PercentChromatographic testsNo resolvable identifier
QuinineLive plantsSolvent extraction11 PercentChromatographic testsNo resolvable identifier
RetrorsineLive plantsSolvent extraction< 0.4 PercentChromatographic testsNo resolvable identifier
RetrorsineLive plantsSolvent extraction11 PercentChromatographic testsNo resolvable identifier
SenecionineLive plantsSolvent extraction< 0.7 PercentChromatographic testsNo resolvable identifier
SenkirkineLive plantsSolvent extraction< 1 PercentChromatographic testsNo resolvable identifier
SolamargineLive plantsSolvent extraction< 4 PercentChromatographic testsNo resolvable identifier
SolasodineLive plantsSolvent extraction< 1 PercentChromatographic testsNo resolvable identifier
SolasonineLive plantsSolvent extraction< 0.2 PercentChromatographic testsNo resolvable identifier
TheobromineLive plantsSolvent extraction< 4.5 PercentChromatographic testsNo resolvable identifier
VeratridineLive plantsSolvent extraction< 0.2 PercentChromatographic testsNo resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
Other toxicitiesSeedSolvent extractionHouse mouse (as animal)Acute toxicityResolve DOI
Other toxicitiesLungSeedSolvent extractionHouse mouse (as animal)Acute toxicityResolve DOI
Other toxicitiesSeedSolvent extractionRat (as animal)SubchronicResolve DOI
Other toxicitiesUrogenital: kidneysSeedSolvent extractionRat (as animal)SubchronicResolve DOI
Other toxicitiesSeedSolvent extractionRat (as animal)SubchronicResolve DOI
Other toxicitiesUrogenital: kidneysSeedSolvent extractionRat (as animal)SubchronicResolve DOI
NoneUnspecifiedHuman (as organism)Case reportNo resolvable identifier
NoneUnspecifiedHuman (as organism)Case reportNo resolvable identifier

Genotoxicity testing

Outcomes of genotoxicity assays as recorded in the source. A negative assay is a result under those test conditions, not a clearance.

OutcomeEndpointTestTested organismMetabolic activationSource
Inconclusivegenome mutationbacterial gene mutation assaySalmonella typhimurium (as organism)No dataNo resolvable identifier
PositiveDNA damage and/or repairbacterial gene mutation assayEscherichia coli (as organism)No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Nardin, Tiziana., Piasentier, Edi., Barnaba, Chiara., Larcher, Roberto. Alkaloid profiling of herbal drugs using high resolution mass spectrometry. Drug testing and analysis, 2017, p. Ahead of Print.
  2. BAUMANN, TW., SCHULTHESS, BH., HANNI, K. GUARANA (PAULLINIA-CUPANA) REWARDS SEED DISPERSERS WITHOUT INTOXICATING THEM BY CAFFEINE . Phytochemistry, 1995, vol. 39, no. 5, p. 1063-&. DOI
  3. Fonseca, Carmen Adilia S. Da., Leal, Jorgelene., Costa, Sonia S., Leitao, Alvaro C. Genotoxic and mutagenic effects of guarana (Paullinia cupana) in prokaryotic organisms . Mutation research, 1994, vol. 321, no. 3, p. 165-173.
  4. Antonelli-Ushirobira, T. M., Kaneshima, E. N., Gabriel, M., Audi, E. A., Marques, L. C., Mello, J. C. P. Acute and subchronic toxicological evaluation of the semipurified extract of seeds of guarand (Paullinia cupana) in rodents . Food and chemical toxicology, 2010, vol. 48, no. 7, p. 1817-1820. DOI
  5. Restani, Patrizia., Di Lorenzo, Chiara., Garcia-Alvarez, Alicia., Badea, Mihaela., Ceschi, Alessandro., Egan, Bernadette., Dima, Lorena., Lude, Saskia., Maggi, Franco M., Marculescu, Angela., . Adverse effects of plant food supplements self-reported by consumers in the PlantLIBRA survey involving six European countries. Plos one, 2016, vol. 11, no. 2, p. e0150089/1-e0150089/20.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue